Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

Skeletal editing is a modern approach to chemical synthesis. By making precise alterations at the atomic level, researchers ...

Discover how hot melt extrusion supports polypharmacy reduction and novel therapies for stroke and snakebite with expert insights.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

As Artificial Intelligence becomes more popular in everyday life, drug research and development companies are incorporating ...

Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more ...

to use an existing COA or sponsors intending to qualify and use a new COA in the drug development process. Our findings show that, to date, the DDT Qualification Program has not significantly improved ...

The FDA made a historic decision to phase out animal testing and switch to human-relevant methods in drug testing and development. Many say animal tests are simply too costly, take too long and ...

Specialty pharmaceuticals are now outpacing traditional drugs and currently account for 52% of the market. A particularly noteworthy development is the emergence of a private-label biosimilar to ...

So do developers of organoids and computer simulations. Drug development has been inching away from animal testing for several years, spurred in part by the 2022 FDA Modernization Act 2.0. But ...